selected publications
-
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant.
Bone marrow transplantation.
2020
Academic Article
GET IT
Times cited: 20 -
The clinical severity of hemoglobin S/Black (A γδβ)0 -thalassemia.
Pediatric blood & cancer.
2017
Article
GET IT
Times cited: 10 -
Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
Clinical trials (London, England).
2016
Academic Article
GET IT
Times cited: 18 -
Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke.
British journal of haematology.
2015
Academic Article
GET IT
Times cited: 41 -
Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
The New England journal of medicine.
2014
Academic Article
GET IT
Times cited: 1158 -
Developments in the treatment of hemophilia B: focus on emerging gene therapy.
The application of clinical genetics.
2013
Information Resource
GET IT
Times cited: 14 -
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
Blood.
2013
Academic Article
GET IT
Times cited: 259 -
Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.
Blood.
2010
Academic Article
GET IT
Times cited: 72